Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Month, Randomized, Double-Blind, Placebo And Positive-Controlled Phase 2b Study To Evaluate The Effect Of Various Doses Of CP-945,598 On Weight Loss In Obese Subjects

NCT00134199 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00134199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00134199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Month, Randomized, Double-Blind, Placebo And Positive-Controlled Phase 2b Study To Evaluate The Effect Of Various Doses Of CP-945,598 On Weight Loss In Obese Subjects
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2005
Completion date
November 30, 2005
Enrollment
282 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

obesity